Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.8 EUR | -0.77% | +0.33% | +16.41% |
05-23 | MERCK KGAA : Receives a Buy rating from UBS | ZD |
05-23 | Merck KGaA: acquisition of U.S.-based Mirus Bio | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.41% | 79.16B | |
+8.35% | 8.72B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B | |
-0.50% | 1.64B | |
-4.94% | 1.51B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Transcript : MERCK Kommanditgesellschaft auf Aktien - Shareholder/Analyst Call